Huron Technologies International Inc.

Huron Technologies International Inc. specializes in digital pathology solutions, specifically whole-slide imaging scanners. Their devices include the TissueScope iQ, TISSUESCOPE LE120, and TissueScope LE, which convert traditional glass slides into digital images. They also offer SlideVault, a software platform designed to store, manage, and organize pathology image data in a centralized digital archive. These tools are primarily used in pathology labs to streamline workflows and improve diagnostic efficiency.

Huron Technologies International Inc. is headquartered in Canada. While the company’s location determines its primary regulatory jurisdiction (e.g., Health Canada), its devices intended for the European market are registered in the EU’s eudamed database. This registration is required for compliance with EU medical device regulations, specifically under the Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR), depending on the device classification. The company’s products listed in eudamed fall under EU Class A classification, which typically involves lower-risk devices.

Huron Technologies International Inc.’s devices are listed in the EU’s eudamed database, which is the official registry for medical devices under EU regulations. Listing in eudamed is important because it demonstrates compliance with EU requirements for traceability and transparency. Authorities, healthcare providers, and other stakeholders can verify the legitimacy and regulatory status of the devices through this database, ensuring they meet the necessary safety, performance, and quality standards before being used in clinical settings.

Huron Technologies International Inc.’s devices are classified as EU Class A medical devices. This classification is determined based on the risk associated with the device’s intended use and potential harm to patients. Class A devices are generally considered the lowest risk, often involving minimal or non-invasive procedures. The classification influences the regulatory pathway, documentation requirements, and oversight needed to ensure compliance with EU safety and performance standards before the devices can be placed on the market.